Generic Design Clause Samples

Generic Design. The performance test tool contains multiple components responsible for the different aspects of load generation and analysis. In the current implementation, these are: • CoAP Server Emulation • Passive Monitoring These components are described in detail in Section 3. The CoAP Server Emulation module is the core component, that focuses on testing the CoAP Client Implementation of the User and managing communication between the testing tool and the VizTools/Result Store. It provides the necessary Resources and routines to test the stability of an IoT Device, whereas the Passive Monitoring module provides the means to monitor and analyse Layer 2-4 network traffic.
Generic Design. The performance test tool contains multiple components responsible for the different aspects of load generation and analysis. In the current implementation, these are: • CoAP Client Emulation • Impairment Generator • Passive Monitoring These components are described in detail in the following sections. The Timeline Controller is the central component of the performance test tool that is responsible for initializing and controlling all other components during the test execution. The Timeline Controller interprets the timeline configuration, constantly calculates the current values for each of the adjustable parameters and sends them to the subcomponents under its control. Per design, the Timeline Controller's function is generic and independent from the specific functions provided by the subcomponents. Each subcomponent provides identical interface to receive configuration or the parameter updates and to generate statistics. This way, the functionality of the test tool can be easily extended with new types of components (e.g. for different protocols) or by extending functionality of existing components without a need to modify the Timeline Controller or any other aspect of the framework.

Related to Generic Design

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.

  • Licensed Product The term “Licensed Product” shall mean any product (a) the manufacture, use, importation, sale or offer for sale of which would, in the absence of the license granted by this Agreement, infringe a Valid Claim of any of the Licensed Patent Rights, or (b) that is comprised of, utilizes or incorporates Licensed Biological Materials, or (c) that is discovered, developed or made using a Licensed Process.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Competing Products The provisions of Section 21 are set forth on attached Exhibit H and are incorporated in this Section 21 by this reference.

  • Product Trademarks BMS shall be solely responsible for the selection (including the creation, searching and clearing), registration, maintenance, policing and enforcement of all trademarks developed for use in connection with the marketing, sale or distribution of Products in the Field in the Territory (the “Product Marks”). BMS shall own all Product Marks, and all trademark registrations for said marks.